Simtuzumab
Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2) . Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC) [1].
Product Specifications
CAS Number
[1318075-13-6]
Product Name Alternative
AB 0024; GS 6624
UNSPSC
12352203
Target
Monoamine Oxidase
Type
Inhibitory Antibodies
Related Pathways
Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/simtuzumab.html
Purity
99.0
Solubility
H2O
Smiles
[Simtuzumab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Wei Chen, et al. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis. Hepatology. 2020 Aug;72 (2) :729-741.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6012296-01 0.1 mg
NFX1 (Transcriptional Repressor NF-X1, Nuclear Transcription Factor, X Box-binding Protein 1, NFX2, DKFZp779G2416, MGC20369)
Ask
View Details MBS6012296-02 5x 0.1 mg
NFX1 (Transcriptional Repressor NF-X1, Nuclear Transcription Factor, X Box-binding Protein 1, NFX2, DKFZp779G2416, MGC20369)
Ask
View Details 
